This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • characteristics of a peripheral facial paralysis ( seen on the affected side) include: (1)
    • unable to wrinkle forehead
    • unable to raise eyebrow
    • unable to wrinkle nasolabial fold
    • unable to purse lips or show teeth
    • inability to completely close eye
    • lacrimation, salivation and taste is likely to be impaired when the lesion is proximal or involving the geniculate ganglion (2)
    • when the lesion is distal to the internal auditory canal and geniculate ganglion lacrimation is intact but, salivation and taste is likely to be impaired (2)
    • decreased taste - indicates a lesion above origin of the chorda tympani
    • hyperacusis -indicates the lesion is above nerve to stapedius
    • reduction of lacrimation - indicates the lesion is above the geniculate ganglion
    • Bell phenomenon
      • on closing the affected eye there is visible vertical rotation of the globe
  • characteristics of a central facial paralysis include: (1)
    • movements of the frontal and upper orbicularis oculi muscles tend to be spared since there are uncrossed contributions from ipsilateral supranuclear areas
    • during emotional expression facial movement may be present on affected side
    • lacrimation, taste, and salivation is intact (2)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.